Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Reducing Complications in Cardiac Ablation Procedures

By HospiMedica staff writers
Posted on 26 Jan 2007
A new technique recommends using continuous nonfluoroscopic imaging to localize the esophagus during radiofrequency catheter ablation (RFA) of atrial fibrillation (AF).

Physicians at Englewood Hospital and Medical Center (NJ, USA) examined 27 patients who underwent 33 pulmonary vein encirclement procedures. More...
All the patients received general anesthesia with inhalational agents. A diagnostic electrophysiologic catheter was inserted into the esophagus, and a virtual esophageal tube was created using an electroanatomic mapping system. Areas of close proximity between the left atrium and esophagus were easily identified. In 12 of 27 patients esophageal proximity to the pulmonary veins identified high-risk cases, and the planned procedure was modified to avoid esophageal injury. The researchers found that among patients who received general anesthesia, the esophageal position appeared to remain static, suggesting that one initial virtual image is sufficient for the duration of an ablation procedure. The new technique is described in a study published in the January 2007 edition of the Journal of Cardiovascular Electrophysiology (JCE).

"This new technique maximizes the effectiveness of the ablation procedure while minimizing the risk of esophageal injury,” said co-author Grant R. Simons, M.D., chief of cardiac electrophysiology at Englewood. "Damage to the esophagus is a rare but very serious complication which is associated with RFA of atrial fibrillation. Our findings present a significant advance in operative safety, and we expect that other centers will adopt this technique.”

Atrial-esophageal fistula formation is a dreaded complication of radiofrequency catheter ablation for AF. Esophageal localization is of potential value in avoiding lesion placement where the left atrium is juxtaposed to the esophagus.



Related Links:
Englewood Hospital and Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.